Characterizing the ILD (interstitial lung disease) Care Continuum Using Real World Evidence
PI(s): Aparna Swaminathan, Duke University
Purpose: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease, affecting over 3 million individuals worldwide and causing progressive lung function deterioration and death within a median of 3-5 years after diagnosis. This project will help to characterize the interstitial lung disease (ILD) patient care continuum across ILD subtypes.
Study Design: Multi-CRN Data Only Observational Study
Sponsor: Industry Partner
Coordinating Center: Duke University